{"gene":"CEBPE","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":2017,"finding":"SMARCD2-containing SWI/SNF chromatin-remodeling complexes are required for CEBPε recruitment to the promoters of neutrophilic secondary granule genes. Loss-of-function mutations in CEBPE that cause specific granule deficiency (SGD) abolish the interaction between CEBPε and SMARCD2/SWI/SNF complexes, thereby blocking secondary granule gene expression.","method":"Genetic knockout mouse model, chromatin immunoprecipitation (ChIP), co-immunoprecipitation, patient mutation analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1–2 — reciprocal Co-IP, ChIP, KO mouse with defined phenotype, validated in patient mutations; multiple orthogonal methods in single study","pmids":["28369034"],"is_preprint":false},{"year":2019,"finding":"A +6-kb enhancer downstream of the CEBPE transcriptional start site interacts with the CEBPE core promoter and is required for CEBPE expression and granulocytic differentiation. CEBPA and CEBPε both bind this enhancer, suggesting autoregulatory control. Germline deletion of this enhancer reduces CEBPE and its target genes and causes severe granulocytic differentiation block.","method":"4C-seq (circular chromosome conformation capture), CRISPRi (dCas9-KRAB), CRISPR/Cas9 germline deletion in mice, ChIP","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including chromosome conformation capture, CRISPRi knockdown, and in vivo germline deletion with defined phenotypic readout","pmids":["30952671"],"is_preprint":false},{"year":2019,"finding":"A homozygous gain-of-function Arg219His mutation in CEBPε causes genome-wide dysregulation of 464 genes via decreased association with transcriptional repressors, leading to increased chromatin occupancy. This results in elevated NLRP3 and constitutively expressed caspase-5 in macrophages, driving noncanonical inflammasome activation.","method":"ChIP-seq, RNA-seq, proteomics, functional inflammasome assays in primary macrophages, patient genetic analysis","journal":"The Journal of allergy and clinical immunology","confidence":"High","confidence_rationale":"Tier 1–2 — genome-wide ChIP-seq and RNA-seq combined with functional inflammasome assay in patient-derived cells, multiple orthogonal methods","pmids":["31201888"],"is_preprint":false},{"year":2018,"finding":"CEBPε transcription factor binds regulatory elements upstream of the Card10 (CARD10) locus to directly activate its transcription during granulopoiesis. Silencing of CARD10 impairs granulocyte differentiation and affects expression of myeloid development genes.","method":"ChIP, Cebpe knockout mice, gene silencing (shRNA/siRNA) in human cell lines and murine primary cells, gene expression analysis","journal":"Haematologica","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP showing direct binding plus KO mouse and knockdown with granulopoiesis phenotype, but single lab","pmids":["29773596"],"is_preprint":false},{"year":2018,"finding":"The heterozygous CEBPE p.Val218Ala mutation causes SGD by preventing nuclear localization of the CEBPε protein, leading to absence of specific granule proteins and altered granule organization in neutrophils.","method":"Proteomic analysis of patient neutrophils, subcellular localization assay, granule distribution analysis","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct localization experiment in patient-derived cells with defined functional consequence, single lab","pmids":["29651288"],"is_preprint":false},{"year":2018,"finding":"The rs2239630 G>A risk allele in the CEBPE promoter increases promoter activity and CEBPE expression. CEBPε binds promoters of electron transport, energy generation, B-cell development (IL7R), apoptosis (BCL2), and methotrexate resistance (RASSF4) genes in ALL cells, and CEBPE depletion reduces ALL cell growth.","method":"Luciferase reporter assay, RNA-seq, ChIP-seq, CEBPE depletion in ALL cell lines","journal":"Leukemia","confidence":"Medium","confidence_rationale":"Tier 1–2 — promoter reporter assay, ChIP-seq, and RNA-seq in multiple cell contexts; single lab but orthogonal methods","pmids":["29977016"],"is_preprint":false},{"year":2025,"finding":"CEBPε deficiency in endplate chondrocytes downregulates lactoferrin (LTF) transcription, which activates the JAK2/STAT3 inflammatory signaling pathway; STAT3 in turn inhibits CEBPε transcription, forming a CEBPE-LTF-STAT3 positive feedback loop that promotes cartilage endplate degeneration.","method":"Gene overexpression/knockdown, transcriptional analysis, lipid nanoparticle delivery in vivo, pathway inhibition assays","journal":"Materials today. Bio","confidence":"Low","confidence_rationale":"Tier 3 — mechanistic loop proposed based on gene expression changes and pathway assays, single lab, limited biochemical validation of direct CEBPε-LTF interaction","pmids":["40677394"],"is_preprint":false},{"year":2025,"finding":"ZMYND8 recognizes the H3K36me2 histone mark via its PWWP domain and activates CEBPE transcription. CEBPε in turn transcriptionally represses ERN1, XBP1, and ATF6 to inhibit adaptive unfolded protein response (UPR) pathways, suppressing multiple myeloma cell survival.","method":"Co-immunoprecipitation, ChIP-seq, transcriptomic analysis, ZMYND8 knockdown in MM cells","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP showing ZMYND8-H3K36me2-CEBPE axis, ChIP-seq confirming occupancy, RNA-seq, KD phenotype; single lab but multiple orthogonal methods","pmids":["40347515"],"is_preprint":false},{"year":2022,"finding":"A homozygous c.655_665del frameshift variant in CEBPE causes SGD through a functionally deficient CEBPε protein with impaired transcriptional activity; aberrant TLR signaling (TLR-4, TLR-2/6, TLR-7/8) is an additional pathogenetic mechanism in SGD type I.","method":"Western blot, luciferase reporter assay, flow cytometry (immunophenotyping, ROS, TLR signaling), RT-PCR","journal":"Journal of clinical immunology","confidence":"Medium","confidence_rationale":"Tier 2 — luciferase reporter and functional TLR signaling assays in patient-derived cells; single lab, multiple functional readouts","pmids":["35726044"],"is_preprint":false},{"year":2025,"finding":"The CEBPE c.655_665del (del11) frameshift variant causes complete loss of DNA-binding ability and cytoplasmic retention (loss of nuclear localization), and abolishes protein-protein interactions with GATA-1 and PU.1 (purine-rich box-1). In contrast, the ΔRS missense variant retains DNA-binding and nuclear localization but loses interactions with GATA-1 and PU.1, defining distinct SGD-1a and SGD-1b subtypes.","method":"Forced expression in embryonic stem cells, subcellular localization assay in NIH3T3 cells, protein-protein interaction assay, DNA-binding assay","journal":"Clinical and experimental immunology","confidence":"Medium","confidence_rationale":"Tier 1–2 — multiple direct biochemical assays (DNA binding, protein interaction, localization) with defined functional consequences, single lab","pmids":["40581342"],"is_preprint":false},{"year":1995,"finding":"CEBPE (CRP1 in the original nomenclature) maps to mouse chromosome 14, syntenic with human 14q11.2, and encodes a basic region-leucine zipper (bZIP) transcription factor of the C/EBP family.","method":"Chromosomal mapping, cDNA sequencing, Northern analysis","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 — direct chromosomal mapping and molecular characterization; foundational identification paper","pmids":["8530045"],"is_preprint":false}],"current_model":"CEBPε is a bZIP transcription factor essential for terminal granulocytic differentiation: it is recruited to secondary granule gene promoters through interaction with SMARCD2-containing SWI/SNF chromatin-remodeling complexes, autoregulates its own expression via a +6-kb enhancer bound by CEBPA and CEBPε, directly activates target genes such as CARD10 and LTF, represses adaptive UPR genes (ERN1, XBP1, ATF6) in plasma cells, and requires nuclear localization and DNA-binding capacity for function—loss-of-function mutations that impair nuclear entry, DNA binding, or co-factor (GATA-1, PU.1, SMARCD2) interactions cause specific granule deficiency, while gain-of-function mutations dysregulate the inflammasome and interferome."},"narrative":{"teleology":[{"year":1995,"claim":"Identifying CEBPE as a novel C/EBP-family bZIP transcription factor and mapping it to mouse chromosome 14 (syntenic with human 14q11.2) established the gene's molecular identity and family membership.","evidence":"Chromosomal mapping, cDNA sequencing, and Northern analysis","pmids":["8530045"],"confidence":"Medium","gaps":["No functional role or target genes defined","Expression pattern across hematopoietic lineages not resolved"]},{"year":2017,"claim":"Demonstrating that CEBPε requires SMARCD2-containing SWI/SNF complexes for recruitment to secondary granule gene promoters — and that SGD-causing mutations abolish this interaction — established the chromatin-remodeling mechanism underlying terminal granulocyte differentiation.","evidence":"ChIP, reciprocal Co-IP, Smarcd2 knockout mice, and patient CEBPE mutation analysis","pmids":["28369034"],"confidence":"High","gaps":["Structural basis of CEBPε–SMARCD2 interaction unknown","Whether other SWI/SNF subunits are independently required not tested"]},{"year":2018,"claim":"Identification of CARD10 as a direct CEBPε target gene during granulopoiesis, and the discovery that a Val218Ala mutation prevents nuclear localization causing SGD, revealed both a downstream effector and a critical requirement for nuclear entry.","evidence":"ChIP on Card10 locus in Cebpe-KO mice plus knockdown in human lines; subcellular localization and proteomic analysis of patient neutrophils with V218A mutation","pmids":["29773596","29651288"],"confidence":"Medium","gaps":["Full repertoire of direct CEBPε target genes in granulopoiesis not defined","Mechanism by which V218A disrupts nuclear import not characterized"]},{"year":2019,"claim":"Discovery that a +6-kb enhancer mediates autoregulatory feedback by CEBPA and CEBPε on CEBPE expression, and that the gain-of-function R219H mutation dysregulates hundreds of genes including NLRP3/caspase-5 inflammasome components, defined both the upstream regulatory circuit and the consequences of unchecked CEBPε activity.","evidence":"4C-seq, CRISPRi, germline enhancer deletion in mice, ChIP (enhancer study); ChIP-seq, RNA-seq, inflammasome assays in patient macrophages (R219H study)","pmids":["30952671","31201888"],"confidence":"High","gaps":["Other transcription factors contributing to +6-kb enhancer activity not identified","How R219H structurally reduces repressor association not resolved"]},{"year":2022,"claim":"Characterization of a homozygous frameshift variant (c.655_665del) as transcriptionally inactive and associated with aberrant TLR signaling linked SGD to innate immune pathway dysregulation beyond granule deficiency.","evidence":"Luciferase reporter assay, TLR signaling by flow cytometry, and RT-PCR in patient-derived cells","pmids":["35726044"],"confidence":"Medium","gaps":["Whether TLR signaling defects are a direct transcriptional consequence of CEBPε loss or secondary","Only one patient studied"]},{"year":2025,"claim":"Biochemical dissection of CEBPε variants showed the del11 frameshift loses DNA binding, nuclear localization, and GATA-1/PU.1 interactions (SGD-1a), whereas the ΔRS missense variant retains DNA binding but loses co-factor interactions (SGD-1b), establishing that CEBPε function requires both DNA-binding capacity and co-factor partnerships.","evidence":"Forced expression in ES cells and NIH3T3 cells with DNA-binding, subcellular localization, and protein–protein interaction assays","pmids":["40581342"],"confidence":"Medium","gaps":["Genome-wide transcriptional consequences of SGD-1b versus SGD-1a not compared","Whether ΔRS variant retains SMARCD2 interaction not tested"]},{"year":2025,"claim":"Identification of CEBPε as a direct transcriptional repressor of adaptive UPR genes (ERN1, XBP1, ATF6) downstream of ZMYND8/H3K36me2 extended its function beyond myeloid differentiation into plasma cell biology.","evidence":"Co-IP, ChIP-seq, RNA-seq, and ZMYND8 knockdown in multiple myeloma cells","pmids":["40347515"],"confidence":"Medium","gaps":["Whether CEBPε directly binds UPR gene promoters or acts indirectly not fully resolved","Relevance to normal plasma cell differentiation not tested"]},{"year":null,"claim":"The structural basis of CEBPε interaction with SMARCD2/SWI/SNF and GATA-1/PU.1, the complete set of direct transcriptional targets during granulopoiesis, and how gain-of-function mutations alter repressor association remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure of CEBPε in complex with any partner","Genome-wide direct target identification by CUT&RUN or equivalent in primary granulocyte progenitors not performed","Mechanism by which R219H reduces repressor binding structurally undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,2,3,5,7,9]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,2,3,5,7,8]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,9]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,2,3,5,7]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,8]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,3]}],"complexes":[],"partners":["SMARCD2","GATA1","SPI1","CEBPA","ZMYND8"],"other_free_text":[]},"mechanistic_narrative":"CEBPE encodes a bZIP transcription factor of the C/EBP family that is essential for terminal granulocytic differentiation and secondary granule gene expression. CEBPE expression is controlled by an autoregulatory +6-kb enhancer bound by both CEBPA and CEBPε, and its transcriptional activity at secondary granule gene promoters requires recruitment through SMARCD2-containing SWI/SNF chromatin-remodeling complexes [PMID:28369034, PMID:30952671]. CEBPε function depends on nuclear localization, DNA-binding capacity, and interactions with co-factors GATA-1 and PU.1; loss-of-function mutations that disrupt any of these properties cause specific granule deficiency (SGD), while a gain-of-function Arg219His mutation increases genome-wide chromatin occupancy and drives constitutive inflammasome activation [PMID:40581342, PMID:31201888]. Beyond myeloid differentiation, CEBPε directly represses adaptive unfolded protein response genes (ERN1, XBP1, ATF6), suppressing plasma cell survival in multiple myeloma [PMID:40347515]."},"prefetch_data":{"uniprot":{"accession":"Q15744","full_name":"CCAAT/enhancer-binding protein epsilon","aliases":[],"length_aa":281,"mass_kda":30.6,"function":"Transcriptional activator (PubMed:26019275). C/EBP are DNA-binding proteins that recognize two different motifs: the CCAAT homology common to many promoters and the enhanced core homology common to many enhancers. Required for the promyelocyte-myelocyte transition in myeloid differentiation (PubMed:10359588)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q15744/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CEBPE","classification":"Not Classified","n_dependent_lines":29,"n_total_lines":1208,"dependency_fraction":0.024006622516556293},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CEBPE","total_profiled":1310},"omim":[{"mim_id":"613065","title":"LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL","url":"https://www.omim.org/entry/613065"},{"mim_id":"601736","title":"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 2; SMARCD2","url":"https://www.omim.org/entry/601736"},{"mim_id":"600749","title":"CCAAT/ENHANCER-BINDING PROTEIN, EPSILON; CEBPE","url":"https://www.omim.org/entry/600749"},{"mim_id":"260570","title":"IMMUNODEFICIENCY 108 WITH AUTOINFLAMMATION; IMD108","url":"https://www.omim.org/entry/260570"},{"mim_id":"245480","title":"SPECIFIC GRANULE DEFICIENCY 1; SGD1","url":"https://www.omim.org/entry/245480"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Plasma membrane","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"bone marrow","ntpm":43.6}],"url":"https://www.proteinatlas.org/search/CEBPE"},"hgnc":{"alias_symbol":["CRP1"],"prev_symbol":[]},"alphafold":{"accession":"Q15744","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15744","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15744-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15744-F1-predicted_aligned_error_v6.png","plddt_mean":63.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CEBPE","jax_strain_url":"https://www.jax.org/strain/search?query=CEBPE"},"sequence":{"accession":"Q15744","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15744.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15744/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15744"}},"corpus_meta":[{"pmid":"12530967","id":"PMC_12530967","title":"Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors.","date":"2003","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/12530967","citation_count":210,"is_preprint":false},{"pmid":"9314536","id":"PMC_9314536","title":"CRP1, a LIM domain protein implicated in muscle differentiation, interacts with alpha-actinin.","date":"1997","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9314536","citation_count":118,"is_preprint":false},{"pmid":"28369034","id":"PMC_28369034","title":"SMARCD2 subunit of SWI/SNF chromatin-remodeling complexes mediates granulopoiesis through a CEBPɛ dependent mechanism.","date":"2017","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28369034","citation_count":62,"is_preprint":false},{"pmid":"16336664","id":"PMC_16336664","title":"Cysteine-rich protein 1 (CRP1) regulates actin filament bundling.","date":"2005","source":"BMC cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16336664","citation_count":59,"is_preprint":false},{"pmid":"10090149","id":"PMC_10090149","title":"The LIM protein, CRP1, is a smooth muscle marker.","date":"1999","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/10090149","citation_count":50,"is_preprint":false},{"pmid":"21889209","id":"PMC_21889209","title":"Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population.","date":"2011","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/21889209","citation_count":49,"is_preprint":false},{"pmid":"23608171","id":"PMC_23608171","title":"Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23608171","citation_count":47,"is_preprint":false},{"pmid":"30952671","id":"PMC_30952671","title":"Identification of a novel enhancer of CEBPE essential for granulocytic differentiation.","date":"2019","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/30952671","citation_count":44,"is_preprint":false},{"pmid":"31201888","id":"PMC_31201888","title":"Gain-of-function CEBPE mutation causes noncanonical autoinflammatory inflammasomopathy.","date":"2019","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31201888","citation_count":42,"is_preprint":false},{"pmid":"23836053","id":"PMC_23836053","title":"Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics.","date":"2013","source":"Cancer causes & control : CCC","url":"https://pubmed.ncbi.nlm.nih.gov/23836053","citation_count":41,"is_preprint":false},{"pmid":"10231520","id":"PMC_10231520","title":"Solution structure of the chicken cysteine-rich protein, CRP1, a double-LIM protein implicated in muscle differentiation.","date":"1999","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10231520","citation_count":35,"is_preprint":false},{"pmid":"9087911","id":"PMC_9087911","title":"Molecular and cellular characterization of CRP1, a Drosophila chromatin decondensation protein.","date":"1997","source":"Journal of structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/9087911","citation_count":34,"is_preprint":false},{"pmid":"9560318","id":"PMC_9560318","title":"LIM domains of cysteine-rich protein 1 (CRP1) are essential for its zyxin-binding function.","date":"1998","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/9560318","citation_count":29,"is_preprint":false},{"pmid":"8530045","id":"PMC_8530045","title":"Mouse chromosomal location of the CCAAT/enhancer binding proteins C/EBP beta (Cebpb), C/EBP delta (Cebpd), and CRP1 (Cebpe).","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8530045","citation_count":27,"is_preprint":false},{"pmid":"29651288","id":"PMC_29651288","title":"CEBPE-Mutant Specific Granule Deficiency Correlates With Aberrant Granule Organization and Substantial Proteome Alterations in Neutrophils.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29651288","citation_count":26,"is_preprint":false},{"pmid":"18177859","id":"PMC_18177859","title":"Cytoskeleton-interacting LIM-domain protein CRP1 suppresses cell proliferation and protects from stress-induced cell death.","date":"2007","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/18177859","citation_count":22,"is_preprint":false},{"pmid":"29977016","id":"PMC_29977016","title":"Genetic predisposition to B-cell acute lymphoblastic leukemia at 14q11.2 is mediated by a CEBPE promoter polymorphism.","date":"2018","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/29977016","citation_count":20,"is_preprint":false},{"pmid":"28261232","id":"PMC_28261232","title":"CRP1 Protein: (dis)similarities between Arabidopsis thaliana and Zea mays.","date":"2017","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/28261232","citation_count":16,"is_preprint":false},{"pmid":"28768142","id":"PMC_28768142","title":"Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.","date":"2017","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/28768142","citation_count":15,"is_preprint":false},{"pmid":"22090504","id":"PMC_22090504","title":"CRP1, a protein localized in filopodia of growth cones, is involved in dendritic growth.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22090504","citation_count":15,"is_preprint":false},{"pmid":"25195121","id":"PMC_25195121","title":"CEBPE polymorphism confers an increased risk of childhood acute lymphoblastic leukemia: a meta-analysis of 11 case-control studies with 5,639 cases and 10,036 controls.","date":"2014","source":"Annals of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/25195121","citation_count":13,"is_preprint":false},{"pmid":"36744908","id":"PMC_36744908","title":"Management of Black Root Disease-Causing Fungus Fusarium solani CRP1 by Endophytic Bacillus siamensis CNE6 through Its Metabolites and Activation of Plant Defense Genes.","date":"2023","source":"Microbiology spectrum","url":"https://pubmed.ncbi.nlm.nih.gov/36744908","citation_count":11,"is_preprint":false},{"pmid":"25938438","id":"PMC_25938438","title":"Association between CEBPE Variant and Childhood Acute Leukemia Risk: Evidence from a Meta-Analysis of 22 Studies.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25938438","citation_count":9,"is_preprint":false},{"pmid":"29773596","id":"PMC_29773596","title":"CARD10, a CEBPE target involved in granulocytic differentiation.","date":"2018","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/29773596","citation_count":8,"is_preprint":false},{"pmid":"7711075","id":"PMC_7711075","title":"cDNA encoding a chicken protein (CRP1) with homology to hnRNP type A/B.","date":"1995","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/7711075","citation_count":8,"is_preprint":false},{"pmid":"23719191","id":"PMC_23719191","title":"Identification of functional nucleotide and haplotype variants in the promoter of the CEBPE gene.","date":"2013","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23719191","citation_count":8,"is_preprint":false},{"pmid":"31867206","id":"PMC_31867206","title":"Association of genes ARID5B, CEBPE and folate pathway with acute lymphoblastic leukemia in a population from the Brazilian Amazon region.","date":"2019","source":"Leukemia research reports","url":"https://pubmed.ncbi.nlm.nih.gov/31867206","citation_count":7,"is_preprint":false},{"pmid":"19027493","id":"PMC_19027493","title":"Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia.","date":"2008","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19027493","citation_count":7,"is_preprint":false},{"pmid":"32936932","id":"PMC_32936932","title":"The cruciform DNA-binding protein Crp1 stimulates the endonuclease activity of Mus81-Mms4 in Saccharomyces cerevisiae.","date":"2020","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/32936932","citation_count":5,"is_preprint":false},{"pmid":"40347515","id":"PMC_40347515","title":"ZMYND8 Reads H3K36me2 to Activate CEBPE Transcription and Suppress Multiple Myeloma Progression through the Inhibition of Adaptive UPR Pathways.","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/40347515","citation_count":4,"is_preprint":false},{"pmid":"32674428","id":"PMC_32674428","title":"Structural Characterization of Black Widow Spider Dragline Silk Proteins CRP1 and CRP4.","date":"2020","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/32674428","citation_count":4,"is_preprint":false},{"pmid":"26388693","id":"PMC_26388693","title":"A common genetic variation in CEBPE and acute lymphoblastic leukemia: a meta-analysis of the available evidence.","date":"2015","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/26388693","citation_count":4,"is_preprint":false},{"pmid":"37273753","id":"PMC_37273753","title":"CRP‑1 promotes the malignant behavior of hepatocellular carcinoma cells via activating epithelial‑mesenchymal transition and Wnt/β‑catenin signaling.","date":"2023","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37273753","citation_count":4,"is_preprint":false},{"pmid":"35726044","id":"PMC_35726044","title":"A Novel CEBPE Variant Causes Severe Infections and Profound Neutropenia.","date":"2022","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35726044","citation_count":3,"is_preprint":false},{"pmid":"37578068","id":"PMC_37578068","title":"ARID5B, IKZF1, GATA3, CEBPE, and CDKN2A germline polymorphisms and predisposition to childhood acute lymphoblastic leukemia.","date":"2023","source":"Pediatric hematology and oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37578068","citation_count":3,"is_preprint":false},{"pmid":"36891039","id":"PMC_36891039","title":"Protein-protein interaction of LDH and CRP-1 with hematotoxin snake venom proteins of all species of snake: An in silico approach.","date":"2023","source":"International journal of health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36891039","citation_count":3,"is_preprint":false},{"pmid":"27007892","id":"PMC_27007892","title":"The complex translocation (9;14;14) involving IGH and CEBPE genes suggests a new subgroup in B-lineage acute lymphoblastic leukemia.","date":"2016","source":"Genetics and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27007892","citation_count":3,"is_preprint":false},{"pmid":"27829304","id":"PMC_27829304","title":"First description of the rs45496295 polymorphism of the C/EBPE gene in β-thalassemia intermedia patients.","date":"2016","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/27829304","citation_count":3,"is_preprint":false},{"pmid":"22137487","id":"PMC_22137487","title":"Double CEBPE-IGH rearrangement due to chromosome duplication and cryptic insertion in an adult with B-cell acute lymphoblastic leukemia.","date":"2011","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22137487","citation_count":2,"is_preprint":false},{"pmid":"40677394","id":"PMC_40677394","title":"Deliver CEBPE via cartilage targeting Lipid nanoparticle to block CEBPE-LTF-STAT3 positive feedback loop for efficient treatment of cartilage endplate degeneration.","date":"2025","source":"Materials today. Bio","url":"https://pubmed.ncbi.nlm.nih.gov/40677394","citation_count":1,"is_preprint":false},{"pmid":"40581342","id":"PMC_40581342","title":"Genotype-phenotype correlations in specific granule deficiency: loss of DNA-binding ability and impaired nuclear localization cause severe manifestations due to the c.655_665del CEBPE variant.","date":"2025","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/40581342","citation_count":1,"is_preprint":false},{"pmid":"40341597","id":"PMC_40341597","title":"A rare case of B-cell acute lymphoblastic leukemia with translocation (14;14)(q11.2;q32) involving IGH and CEBPE with review of the literature.","date":"2025","source":"Journal of hematopathology","url":"https://pubmed.ncbi.nlm.nih.gov/40341597","citation_count":0,"is_preprint":false},{"pmid":"36897378","id":"PMC_36897378","title":"Significance of CEBPE Gene Promoter Polymorphism (Rs2239630 G > A ) Assessment in Childhood B-cell Acute Lymphoblastic Leukemia.","date":"2023","source":"Journal of pediatric hematology/oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36897378","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.11.25.690588","title":"Atmospheric hydrogen consumption is regulated by catabolite repression in mycobacteria","date":"2025-11-26","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.25.690588","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":22859,"output_tokens":2728,"usd":0.054748},"stage2":{"model":"claude-opus-4-6","input_tokens":6151,"output_tokens":2126,"usd":0.125858},"total_usd":0.180606,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2017,\n      \"finding\": \"SMARCD2-containing SWI/SNF chromatin-remodeling complexes are required for CEBPε recruitment to the promoters of neutrophilic secondary granule genes. Loss-of-function mutations in CEBPE that cause specific granule deficiency (SGD) abolish the interaction between CEBPε and SMARCD2/SWI/SNF complexes, thereby blocking secondary granule gene expression.\",\n      \"method\": \"Genetic knockout mouse model, chromatin immunoprecipitation (ChIP), co-immunoprecipitation, patient mutation analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reciprocal Co-IP, ChIP, KO mouse with defined phenotype, validated in patient mutations; multiple orthogonal methods in single study\",\n      \"pmids\": [\"28369034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A +6-kb enhancer downstream of the CEBPE transcriptional start site interacts with the CEBPE core promoter and is required for CEBPE expression and granulocytic differentiation. CEBPA and CEBPε both bind this enhancer, suggesting autoregulatory control. Germline deletion of this enhancer reduces CEBPE and its target genes and causes severe granulocytic differentiation block.\",\n      \"method\": \"4C-seq (circular chromosome conformation capture), CRISPRi (dCas9-KRAB), CRISPR/Cas9 germline deletion in mice, ChIP\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including chromosome conformation capture, CRISPRi knockdown, and in vivo germline deletion with defined phenotypic readout\",\n      \"pmids\": [\"30952671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A homozygous gain-of-function Arg219His mutation in CEBPε causes genome-wide dysregulation of 464 genes via decreased association with transcriptional repressors, leading to increased chromatin occupancy. This results in elevated NLRP3 and constitutively expressed caspase-5 in macrophages, driving noncanonical inflammasome activation.\",\n      \"method\": \"ChIP-seq, RNA-seq, proteomics, functional inflammasome assays in primary macrophages, patient genetic analysis\",\n      \"journal\": \"The Journal of allergy and clinical immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genome-wide ChIP-seq and RNA-seq combined with functional inflammasome assay in patient-derived cells, multiple orthogonal methods\",\n      \"pmids\": [\"31201888\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CEBPε transcription factor binds regulatory elements upstream of the Card10 (CARD10) locus to directly activate its transcription during granulopoiesis. Silencing of CARD10 impairs granulocyte differentiation and affects expression of myeloid development genes.\",\n      \"method\": \"ChIP, Cebpe knockout mice, gene silencing (shRNA/siRNA) in human cell lines and murine primary cells, gene expression analysis\",\n      \"journal\": \"Haematologica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP showing direct binding plus KO mouse and knockdown with granulopoiesis phenotype, but single lab\",\n      \"pmids\": [\"29773596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The heterozygous CEBPE p.Val218Ala mutation causes SGD by preventing nuclear localization of the CEBPε protein, leading to absence of specific granule proteins and altered granule organization in neutrophils.\",\n      \"method\": \"Proteomic analysis of patient neutrophils, subcellular localization assay, granule distribution analysis\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct localization experiment in patient-derived cells with defined functional consequence, single lab\",\n      \"pmids\": [\"29651288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The rs2239630 G>A risk allele in the CEBPE promoter increases promoter activity and CEBPE expression. CEBPε binds promoters of electron transport, energy generation, B-cell development (IL7R), apoptosis (BCL2), and methotrexate resistance (RASSF4) genes in ALL cells, and CEBPE depletion reduces ALL cell growth.\",\n      \"method\": \"Luciferase reporter assay, RNA-seq, ChIP-seq, CEBPE depletion in ALL cell lines\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — promoter reporter assay, ChIP-seq, and RNA-seq in multiple cell contexts; single lab but orthogonal methods\",\n      \"pmids\": [\"29977016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CEBPε deficiency in endplate chondrocytes downregulates lactoferrin (LTF) transcription, which activates the JAK2/STAT3 inflammatory signaling pathway; STAT3 in turn inhibits CEBPε transcription, forming a CEBPE-LTF-STAT3 positive feedback loop that promotes cartilage endplate degeneration.\",\n      \"method\": \"Gene overexpression/knockdown, transcriptional analysis, lipid nanoparticle delivery in vivo, pathway inhibition assays\",\n      \"journal\": \"Materials today. Bio\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — mechanistic loop proposed based on gene expression changes and pathway assays, single lab, limited biochemical validation of direct CEBPε-LTF interaction\",\n      \"pmids\": [\"40677394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ZMYND8 recognizes the H3K36me2 histone mark via its PWWP domain and activates CEBPE transcription. CEBPε in turn transcriptionally represses ERN1, XBP1, and ATF6 to inhibit adaptive unfolded protein response (UPR) pathways, suppressing multiple myeloma cell survival.\",\n      \"method\": \"Co-immunoprecipitation, ChIP-seq, transcriptomic analysis, ZMYND8 knockdown in MM cells\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP showing ZMYND8-H3K36me2-CEBPE axis, ChIP-seq confirming occupancy, RNA-seq, KD phenotype; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"40347515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A homozygous c.655_665del frameshift variant in CEBPE causes SGD through a functionally deficient CEBPε protein with impaired transcriptional activity; aberrant TLR signaling (TLR-4, TLR-2/6, TLR-7/8) is an additional pathogenetic mechanism in SGD type I.\",\n      \"method\": \"Western blot, luciferase reporter assay, flow cytometry (immunophenotyping, ROS, TLR signaling), RT-PCR\",\n      \"journal\": \"Journal of clinical immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — luciferase reporter and functional TLR signaling assays in patient-derived cells; single lab, multiple functional readouts\",\n      \"pmids\": [\"35726044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The CEBPE c.655_665del (del11) frameshift variant causes complete loss of DNA-binding ability and cytoplasmic retention (loss of nuclear localization), and abolishes protein-protein interactions with GATA-1 and PU.1 (purine-rich box-1). In contrast, the ΔRS missense variant retains DNA-binding and nuclear localization but loses interactions with GATA-1 and PU.1, defining distinct SGD-1a and SGD-1b subtypes.\",\n      \"method\": \"Forced expression in embryonic stem cells, subcellular localization assay in NIH3T3 cells, protein-protein interaction assay, DNA-binding assay\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple direct biochemical assays (DNA binding, protein interaction, localization) with defined functional consequences, single lab\",\n      \"pmids\": [\"40581342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"CEBPE (CRP1 in the original nomenclature) maps to mouse chromosome 14, syntenic with human 14q11.2, and encodes a basic region-leucine zipper (bZIP) transcription factor of the C/EBP family.\",\n      \"method\": \"Chromosomal mapping, cDNA sequencing, Northern analysis\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct chromosomal mapping and molecular characterization; foundational identification paper\",\n      \"pmids\": [\"8530045\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CEBPε is a bZIP transcription factor essential for terminal granulocytic differentiation: it is recruited to secondary granule gene promoters through interaction with SMARCD2-containing SWI/SNF chromatin-remodeling complexes, autoregulates its own expression via a +6-kb enhancer bound by CEBPA and CEBPε, directly activates target genes such as CARD10 and LTF, represses adaptive UPR genes (ERN1, XBP1, ATF6) in plasma cells, and requires nuclear localization and DNA-binding capacity for function—loss-of-function mutations that impair nuclear entry, DNA binding, or co-factor (GATA-1, PU.1, SMARCD2) interactions cause specific granule deficiency, while gain-of-function mutations dysregulate the inflammasome and interferome.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CEBPE encodes a bZIP transcription factor of the C/EBP family that is essential for terminal granulocytic differentiation and secondary granule gene expression. CEBPE expression is controlled by an autoregulatory +6-kb enhancer bound by both CEBPA and CEBPε, and its transcriptional activity at secondary granule gene promoters requires recruitment through SMARCD2-containing SWI/SNF chromatin-remodeling complexes [PMID:28369034, PMID:30952671]. CEBPε function depends on nuclear localization, DNA-binding capacity, and interactions with co-factors GATA-1 and PU.1; loss-of-function mutations that disrupt any of these properties cause specific granule deficiency (SGD), while a gain-of-function Arg219His mutation increases genome-wide chromatin occupancy and drives constitutive inflammasome activation [PMID:40581342, PMID:31201888]. Beyond myeloid differentiation, CEBPε directly represses adaptive unfolded protein response genes (ERN1, XBP1, ATF6), suppressing plasma cell survival in multiple myeloma [PMID:40347515].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Identifying CEBPE as a novel C/EBP-family bZIP transcription factor and mapping it to mouse chromosome 14 (syntenic with human 14q11.2) established the gene's molecular identity and family membership.\",\n      \"evidence\": \"Chromosomal mapping, cDNA sequencing, and Northern analysis\",\n      \"pmids\": [\"8530045\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional role or target genes defined\", \"Expression pattern across hematopoietic lineages not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating that CEBPε requires SMARCD2-containing SWI/SNF complexes for recruitment to secondary granule gene promoters — and that SGD-causing mutations abolish this interaction — established the chromatin-remodeling mechanism underlying terminal granulocyte differentiation.\",\n      \"evidence\": \"ChIP, reciprocal Co-IP, Smarcd2 knockout mice, and patient CEBPE mutation analysis\",\n      \"pmids\": [\"28369034\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of CEBPε–SMARCD2 interaction unknown\", \"Whether other SWI/SNF subunits are independently required not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identification of CARD10 as a direct CEBPε target gene during granulopoiesis, and the discovery that a Val218Ala mutation prevents nuclear localization causing SGD, revealed both a downstream effector and a critical requirement for nuclear entry.\",\n      \"evidence\": \"ChIP on Card10 locus in Cebpe-KO mice plus knockdown in human lines; subcellular localization and proteomic analysis of patient neutrophils with V218A mutation\",\n      \"pmids\": [\"29773596\", \"29651288\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Full repertoire of direct CEBPε target genes in granulopoiesis not defined\", \"Mechanism by which V218A disrupts nuclear import not characterized\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovery that a +6-kb enhancer mediates autoregulatory feedback by CEBPA and CEBPε on CEBPE expression, and that the gain-of-function R219H mutation dysregulates hundreds of genes including NLRP3/caspase-5 inflammasome components, defined both the upstream regulatory circuit and the consequences of unchecked CEBPε activity.\",\n      \"evidence\": \"4C-seq, CRISPRi, germline enhancer deletion in mice, ChIP (enhancer study); ChIP-seq, RNA-seq, inflammasome assays in patient macrophages (R219H study)\",\n      \"pmids\": [\"30952671\", \"31201888\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Other transcription factors contributing to +6-kb enhancer activity not identified\", \"How R219H structurally reduces repressor association not resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Characterization of a homozygous frameshift variant (c.655_665del) as transcriptionally inactive and associated with aberrant TLR signaling linked SGD to innate immune pathway dysregulation beyond granule deficiency.\",\n      \"evidence\": \"Luciferase reporter assay, TLR signaling by flow cytometry, and RT-PCR in patient-derived cells\",\n      \"pmids\": [\"35726044\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether TLR signaling defects are a direct transcriptional consequence of CEBPε loss or secondary\", \"Only one patient studied\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Biochemical dissection of CEBPε variants showed the del11 frameshift loses DNA binding, nuclear localization, and GATA-1/PU.1 interactions (SGD-1a), whereas the ΔRS missense variant retains DNA binding but loses co-factor interactions (SGD-1b), establishing that CEBPε function requires both DNA-binding capacity and co-factor partnerships.\",\n      \"evidence\": \"Forced expression in ES cells and NIH3T3 cells with DNA-binding, subcellular localization, and protein–protein interaction assays\",\n      \"pmids\": [\"40581342\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Genome-wide transcriptional consequences of SGD-1b versus SGD-1a not compared\", \"Whether ΔRS variant retains SMARCD2 interaction not tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identification of CEBPε as a direct transcriptional repressor of adaptive UPR genes (ERN1, XBP1, ATF6) downstream of ZMYND8/H3K36me2 extended its function beyond myeloid differentiation into plasma cell biology.\",\n      \"evidence\": \"Co-IP, ChIP-seq, RNA-seq, and ZMYND8 knockdown in multiple myeloma cells\",\n      \"pmids\": [\"40347515\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether CEBPε directly binds UPR gene promoters or acts indirectly not fully resolved\", \"Relevance to normal plasma cell differentiation not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of CEBPε interaction with SMARCD2/SWI/SNF and GATA-1/PU.1, the complete set of direct transcriptional targets during granulopoiesis, and how gain-of-function mutations alter repressor association remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal or cryo-EM structure of CEBPε in complex with any partner\", \"Genome-wide direct target identification by CUT&RUN or equivalent in primary granulocyte progenitors not performed\", \"Mechanism by which R219H reduces repressor binding structurally undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 2, 3, 5, 7, 9]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 2, 3, 5, 7, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 2, 3, 5, 7]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 8]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"SMARCD2\",\n      \"GATA1\",\n      \"SPI1\",\n      \"CEBPA\",\n      \"ZMYND8\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}